Milestone Pharmaceuticals
MIST
MIST
29 hedge funds and large institutions have $116M invested in Milestone Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $135M → $116M (-$19.1M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
29
Holding in Top 10
–
Calls
$1.77M
Puts
$273K
Top Buyers
| 1 | +$3.07M | |
| 2 | +$1.57M | |
| 3 | +$1.56M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$475K |
| 5 |
Millennium Management
New York
|
+$412K |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$318K | |
| 3 | -$92.2K | |
| 4 |
PP
PDT Partners
New York
|
-$65K |
| 5 |
JPMorgan Chase & Co
New York
|
-$59.6K |